Vector Science & Therapeutics Corp. (TSXV: PAIN) today announced the appointment of Dexter Fowler as Chief Athletic Officer ...
Option agreement Supports Vector's Entry into the $80.8 Billion Peptide Market with 22 Novel Pharmaceutical-Grade Formulations MEQUON, Wis., May 13, 2026 /PRNewswire/ -- Vector Science & Therapeutics ...
Dr. Alexander Dobranowski, President, Director, and Co-Founder of HEALWELL AI, brings healthcare AI and clinical leadership to the Vector board. Scott Kelly, a proven C-level leader with 22+ years of ...
Former Wisconsin Governor and U.S. Secretary of Health and Human Services Brings Extensive Healthcare Leadership to Pioneer of Transdermal Drug Delivery Technology MEQUON, Wis., April 30, 2026 ...
ST. LOUIS--(BUSINESS WIRE)--Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, today announced the merger of its portfolio companies, Vector Laboratories and Absolute ...
Option agreement Supports Vector's Entry into the $80.8 Billion Peptide Market with 22 Novel Pharmaceutical-Grade Formulations FDA-Registered, cGMP Manufacturing-- MPP operates a modern 35,000 sq. ft.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results